- HOME
- Rinsho Shinkeigaku (Clinical Neurology)
- Vol.50 No.11
Vol.50 No.11 contents
The 51st Annual Meeting of the Japanese Society of Neurology
Future directions of Neurology
-Breakthrough to the next stage-
Shoji Tsuji
CLINICA NEUROL, 50: 771|777, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
<Plenary Lecture>
World Neurology: Challenges, Opportunities and Priorities
Vladimir Hachinski, M.D.
CLINICA NEUROL, 50: 778|778, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Elucidation of pathomechanism and development of therapy for autophagic vacuolar myopathy
Ichizo Nishino, M.D.
CLINICA NEUROL, 50: 779|779, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
The discovery of an antiparkinsonian drug, zonisamide
Miho Murata, M.D., Ph.D.
CLINICA NEUROL, 50: 780|782, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Diagnosis and treatment in acute stroke
Kazumi Kimura, M.D.
CLINICA NEUROL, 50: 783|786, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Neurological aspects of leprosy
Makoto Iwata, M.D.
CLINICA NEUROL, 50: 787|787, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases
Jun-ichi Kira, M.D., Ph.D.
CLINICA NEUROL, 50: 788|793, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
New treatment strategy for Crow-Fukase (POEMS) syndrome
Satoshi Kuwabara, M.D.
CLINICA NEUROL, 50: 794|796, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Prion disease
Hidehiro Mizusawa, M.D., Ph.D.
CLINICA NEUROL, 50: 797|802, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Transcranial magnetic stimulation (TMS) in clinical neurology
Hideyuki Matsumoto, M.D.1) and Yoshikazu Ugawa, M.D.2)
CLINICA NEUROL, 50: 803|807, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Japanese Guidelines for the Management of Stroke 2009
-Important revised points necessary for the neurologist-
Yukito Shinohara, M.D.
CLINICA NEUROL, 50: 808|811, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Guideline for gene diagnosis of neurological disorders, 2009
Jun Goto, M.D.
CLINICA NEUROL, 50: 812|812, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Antibody-related neuroimmunological disorders: Update on the diagnosis and treatment
Keiko Tanaka, M.D.
CLINICA NEUROL, 50: 813|815, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Intrathecal baclofen therapy
Takaomi Taira, M.D.
CLINICA NEUROL, 50: 816|819, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Amyloid imaging up to date
Kenji Ishii, M.D.
CLINICA NEUROL, 50: 820|820, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Reading the mind from brain activity
Yukiyasu Kamitani, M.D.
CLINICA NEUROL, 50: 821|821, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Integrative neuroimaging for schizophrenia targeting early intervention and prevention (IN-STEP)
Kiyoto Kasai, M.D.
CLINICA NEUROL, 50: 822|824, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
<East Asian Neurology Forum 1>
Clinical Practice Guideline for Stroke in Korea
Hee-Joon Bae, M.D.
CLINICA NEUROL, 50: 825|825, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
<East Asian Neurology Forum 2>
Acute Stroke Management in Japan
Yasuyuki Iguchi, M.D. and Kazumi Kimura, M.D.
CLINICA NEUROL, 50: 826|826, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
<East Asian Neurology Forum 3>
Stroke in China-Past, Present and Future
Chuanzhen Lu, M.D.
CLINICA NEUROL, 50: 827|827, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
<East Asian Neurology Forum 4>
Acute management and research of stroke in Taiwan: an update
Chih-Ping Chung, M.D. and Han-Hwa Hu, Professor
CLINICA NEUROL, 50: 828|829, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Aim
Gen Sobue, M.D.1), Hiroshi Mitsumoto, M.D.2)
CLINICA NEUROL, 50: 830|830, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Disease-modifying Therapies in PD
Olivier Rascol, M.D.
CLINICA NEUROL, 50: 831|831, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Results of the Cilostazol Stroke Prevention Study II (CSPS II), a randomized controlled trial for the comparison of cilostazol and aspirin in stroke patients
Shinichiro Uchiyama, M.D.
CLINICA NEUROL, 50: 832|834, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Clinical Trials in AD
Rachelle S. Doody, M.D., Ph.D.
CLINICA NEUROL, 50: 835|835, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Familial Amyloid Polyneuropathy: Diflunisal
Yoshiki Sekijima, M.D.
CLINICA NEUROL, 50: 836|836, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Aim
Shu-ichi Ikeda, M.D.1), Atsushi Iwata, M.D.2)
CLINICA NEUROL, 50: 837|837, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Aβ42Gene Vaccine for Prevention and Treatment of Alzheimer's Disease
Roger N. Rosenberg, M.D.
CLINICA NEUROL, 50: 838|838, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Molecular-targeted therapy for spinal and bulbar muscular atrophy (SBMA)
Gen Sobue, M.D.
CLINICA NEUROL, 50: 839|841, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Gene Therapy Starts to Tackle CNS Disease
Patrick Aubourg, M.D.
CLINICA NEUROL, 50: 842|842, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Antisense Oligos for Muscular Dystrophy
Tetsuya Nagata, M.D. and Shinichi Takeda, M.D.
CLINICA NEUROL, 50: 843|843, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Therapeutic approaches for patients with adult-onset type II citrullinemia (CTLN2):effectiveness of treatment with low-carbohydrate diet and sodium pyruvate
Masahide Yazaki, M.D.1), Shu-ichi Ikeda, M.D.1), Keiko Kobayashi, Ph.D.2), and Takeyori Saheki, M.D.3)
CLINICA NEUROL, 50: 844|847, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 50: 848|848, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
CARASIL: Identification of the clinical concept
Toshio Fukutake, M.D., Ph.D.
CLINICA NEUROL, 50: 849|851, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Molecular mechanism and therapeutic strategy for cerebral small vessel disease
Kenju Hara, M.D., Ph.D.
CLINICA NEUROL, 50: 852|854, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Familial Wernicke's-like encephalopathy
Hiroaki Miyajima, M.D. and Satoshi Kono
CLINICA NEUROL, 50: 855|857, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
SCA6: From gene identification to recent progress on pathogenesis
Kei Watase, M.D.1), Kinya Ishikawa, M.D.2) and Hidehiro Mizusawa, M.D.1)2)
CLINICA NEUROL, 50: 858|860, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Amyotrophic lateral sclerosis associated with mutations in the SOD1 gene
Masashi Aoki, M.D.
CLINICA NEUROL, 50: 861|861, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 50: 862|862, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Molecular Genetics of Familial Parkinson's disease
Nobutaka Hattori
CLINICA NEUROL, 50: 863|863, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Gene for sporadic Parkinson's disease: Common disease-common variants
Tatsushi Toda, M.D. and Wataru Satake, M.D.
CLINICA NEUROL, 50: 864|864, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Genetic basis of sponadic Parkinson disease: common disease-multiple rare variants
Jun Mitsui, M.D.
CLINICA NEUROL, 50: 865|866, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Mechanisms underling the cause of Parkinson's disease: The functions of Parkin/PINK1
Keiji Tanaka, M.D., Noriyuki Matsuda, M.D. and Kei Okatsu, M.D.
CLINICA NEUROL, 50: 867|867, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Aim
Akio Suzumura1), Susumu Kusunoki2)
CLINICA NEUROL, 50: 868|868, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Promoting Remyelination by Reducing an Inhibitory Microenvironment
V. Wee Yong, M.D.
CLINICA NEUROL, 50: 869|869, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Blueprint for the Development of Remyelination Medicines for Multiple Sclerosis
Jin Nakahara, M.D.,Ph.D.
CLINICA NEUROL, 50: 870|870, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Microglia and Neuronal Degeneration
Akio Suzumura, M.D.
CLINICA NEUROL, 50: 871|871, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Pathogenesis of Neuromyelitis Optica: aquaporin 4 autoimmunity and astrocytopathy
Tatsuro Misu, M.D.1), Kazuo Fujihara, M.D.1)2), Toshiyuki Takahashi, M.D.1), Rina Takano, M.D.1), Shuhei Nishiyama, M.D.1), Yoshiki Takai, M.D.1), Ichiro Nakashima, M.D.1), Shigeru Sato, M.D.3), Hans Lassmann, M.D.4) and Yasuto Itoyama, M.D.1)
CLINICA NEUROL, 50: 872|872, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Humoral and cellular immune responses in neuromyelitis optica
Izumi Kawachi, M.D., Ph.D.
CLINICA NEUROL, 50: 873|874, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Aim
Shinichi Takahashi1), Gregory J. del Zoppo2)
CLINICA NEUROL, 50: 875|875, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Regulating the Responses of the Neurovascular Unit to Focal Ischemia
Gregory J. del Zoppo, M.D.
CLINICA NEUROL, 50: 876|877, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Role of T lymphocytes in ischemic brain injury
Takashi Shichita, M.D., PhD.1)2), Fumie Konoeda, M.D., PhD.1)3) and Akihiko Yoshimura, PhD.1)
CLINICA NEUROL, 50: 878|880, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
The involvement of endoplasmic reticulum stress in pathogenesis after cerebral ischemia
Hideaki Hara, Ph.D.
CLINICA NEUROL, 50: 881|881, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Immunomodulation by inducing tolerance to E-selectin and adult neurogenesis after stroke
Satoru Ishibashi, M.D., Ph.D.
CLINICA NEUROL, 50: 882|885, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Aim
Haruhisa Inoue1), Hideyuki Okano2)
CLINICA NEUROL, 50: 886|886, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Investigation of regeneration of damaged CNS and neurological diseases mechanisms using iPS cells
Hideyuki Okano, M.D.
CLINICA NEUROL, 50: 887|887, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Migration of new neurons towards the injured brain tissue
Kazunobu Sawamoto, Ph.D.
CLINICA NEUROL, 50: 888|888, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Derivation of Engraftable Myogenic Precursors from Murine ES/iPS cells and Generation of Disease-specific iPS cells from Patients with Duchenne Muscular dystrophy (DMD) and Other Diseases
Tatsutoshi Nakahata, M.D.1)4), Tomonari Awaya, M.D.1), Hsi Chang, M.D.1), Yuta Mizuno, M.D.1), Akira Niwa, M.D.1)4), So-ichiro Fukada, M.D.2), Shin'ichi Takeda, M.D.3), Shinya Yamanaka, M.D.4) and Toshio Heike, M.D.1)
CLINICA NEUROL, 50: 889|889, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Simple Test for Evaluation the Safeness of Human Induced Pluripotent Stem Cells
Kazutoshi Takahashi, M.D.
CLINICA NEUROL, 50: 890|890, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Opportunities for neurorestorative therapies in PD using iPS and stem cells
Isacson Ole, M.D.
CLINICA NEUROL, 50: 891|891, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Aim
Tatsuya Tanaka1), Sadatoshi Tsuji2)
CLINICA NEUROL, 50: 892|892, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Why Don't Medicines for Epilepsy Always Work?
Edward H. Bertram, M.D.
CLINICA NEUROL, 50: 893|893, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Selection of proper antiepileptic drugs
Sunao Kaneko, M.D. and Shuichi Yoshida, M.D.
CLINICA NEUROL, 50: 894|894, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Clinical characteristics and treatment for new onset epilepsy in the elderly
Naoki Akamatsu, M.D.
CLINICA NEUROL, 50: 895|895, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Is the Genetic Diagnosis of Epilepsy Useful in Clinical Practice?
Shinichi Hirose, M.D.
CLINICA NEUROL, 50: 896|896, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 50: 897|897, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Connections among motor-related areas revealed by resting-state functional connectivity MRI
Toshihiro Hayashi, M.D.,Ph.D.
CLINICA NEUROL, 50: 898|898, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Change in functional connectivity between the primary motor cortex and nucleus accumbens during the recovery from the lesion of the corticospinal tract in monkeys
Tadashi Isa, M.D.
CLINICA NEUROL, 50: 899|899, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Quadripulse stimulation (QPS) of the human cortex
Masashi Hamada, M.D.1) and Yoshikazu Ugawa, M.D.2)
CLINICA NEUROL, 50: 900|900, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Multidimensional neuroimaging approach for studying brain network
Takashi Hanakawa, M.D., Ph.D.
CLINICA NEUROL, 50: 901|902, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 50: 903|903, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
New Definition and Concept of TIA
Shinichiro Uchiyama, M.D.
CLINICA NEUROL, 50: 904|906, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Kazuo Minematsu, M.D.
CLINICA NEUROL, 50: 907|908, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
The first stage examination and therapy for patients with TIA
Yasushi Okada, M.D., Mayumi Mori, M.D., Yoshiyuki Wakugawa, M.D. and Masahiro Yasaka, M.D.
CLINICA NEUROL, 50: 909|909, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
New clinical concept and therapeutic strategy for TIA
Takao Urabe, M.D., Ph.D.
CLINICA NEUROL, 50: 910|912, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 50: 913|913, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
The concept of branch atheromatous disease (BAD) and its clinical significance
Yasumasa Yamamoto, M.D., Tomoyuki Ohara, M.D., Yoshinari Nagakane, M.D., Eijiro Tanaka, M.D., Fukiko Morii, M.D. and Takashi Koizumi, M.D.
CLINICA NEUROL, 50: 914|917, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Topics on the forefront of diagnosis of stroke Branch atheromatous disease (BAD)
Yasuo Terayama
CLINICA NEUROL, 50: 918|918, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Neurological progression and clinical outcome of branch athromatous disease
(Results from the J-BAD registry)
Haruhiko Hoshino, M.D.1), Makoto Takagi, M.D.2), Yasumasa Yamamoto, M.D.3), Yasuhiro Ishibashi, M.D.4), Yasuo Terayama, M.D.4), Hidetaka Takeda, M.D.5), Norio Tanahashi, M.D.5), Tomohide Adachi, M.D.2), Yoshiharu Taguchi, M.D.6)7), Shutaro Takashima, M.D.7), Kortaro Tanaka, M.D.7), Keizo Yasui, M.D.8) and Norihiro Suzuki, M.D.1)
CLINICA NEUROL, 50: 919|920, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Branch atheromatous disease: How do we analyze its pathophysiology and treat to prevent the progression of neurological symptoms for good prognosis?
Hidetaka Takeda, M.D.1), Makoto Takagi, M.D.2), Yasumasa Yamamoto, M.D.3) and J-BAD Investigators4)
CLINICA NEUROL, 50: 921|924, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Aim
Osamu Onodera1), Kenji Nakashima2)
CLINICA NEUROL, 50: 925|925, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Natural History Studies and the EUROSCA Clinical Research Network
Thomas Klockgether, M.D.
CLINICA NEUROL, 50: 926|926, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Japan Multiple System Atrophy Research Consortium (JAMSAC)
Yaeko Ichikawa, M.D., PhD
CLINICA NEUROL, 50: 927|927, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Japanese consortium for amyotrophic lateral sclerosis researchiJaCALSj
Naoki Atsuta, M.D.1) and Gen Sobue, M.D.2)
CLINICA NEUROL, 50: 928|930, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Japan spastic paraplegia research consortium (JASPAC)
Yoshihisa Takiyama, M.D.1), Hiroyuki Ishiura, M.D.2), Haruo Shimazaki, M.D.3), Michito Namekawa, M.D.3), Yuji Takahashi, M.D.2), Jun Goto, M.D.2), Shoji Tsuji, M.D.2) and Masatoyo Nishizawa, M.D.4)
CLINICA NEUROL, 50: 931|934, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
J-ADNI
Takeshi Iwatsubo, M.D.
CLINICA NEUROL, 50: 935|935, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 50: 936|936, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Molecular dissection of TDP-43 in ALS and FTLD
Masato Hasegawa, M.D.1), Tetsuaki Arai, M.D.2)3), Takashi Nonaka, M.D.1), Hiroshi Tsuji, M.D.1)4), Makiko Yamashita, M.D.1), Masato Hosokawa, M.D.2), Fuyuki Kametani, M.D.1), Akira Tamaoka, M.D.4) and Haruhiko Akiyama, M.D.2)
CLINICA NEUROL, 50: 937|939, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
The clinical and pathological spectrum of TDP-43 associated ALS
Osamu Onodera, M.D.1), Akio Yokoseki, M.D.2), Chun-Feng Tan, M.D.3), Tomohiko Ishihara, M.D.1)2), Yasushi Nishiira, M.D.3), Yasuko Toyoshima, M.D.3), Akiyoshi Kakita, M.D.3), Masatoyo Nishizawa, M.D.2) and Hitoshi Takahashi, M.D.3)
CLINICA NEUROL, 50: 940|942, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Animal model of ALS by overexpression of TDP-43
Takanori Yokota, M.D.
CLINICA NEUROL, 50: 943|944, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
FUS/TLS as a polyglutamine aggregate interacting protein
Nobuyuki Nukina, M.D.
CLINICA NEUROL, 50: 945|947, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Clinical and pathological characteristics of FUS/TLS-associated amyotrophic lateral sclerosis (ALS)
Shigeo Murayama, M.D., Ph.D.
CLINICA NEUROL, 50: 948|950, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Aim
Tatsushi Toda1), Hidenao Sasaki2)
CLINICA NEUROL, 50: 951|951, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Whole Exome Sequencing
Karen Nuytemans, Ph.D. and Jeffery M. Vance, M.D., Ph.D.
CLINICA NEUROL, 50: 952|955, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Exploring the Responsible Gene for a Familial ALS by Next-generation Sequencer
Tadashi Kaname, M.D.1), Akira Tsujino, M.D.2) and Koichiro Yoshiura, M.D.3),
CLINICA NEUROL, 50: 956|956, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Massively parallel sequence analysis for revealing causes of neuromuscular disorders
Hiroyuki Ishiura, M.D. and Shoji Tsuji, M.D.
CLINICA NEUROL, 50: 957|958, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 50: 959|959, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Etsuro Mori, M.D.
CLINICA NEUROL, 50: 960|962, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
iNPH (Idiopathic normal pressure hydrocephalus) and AVIM (asymptomatic ventriculomegaly with features of iNPH on MRI)
Takeo Kato, M.D.1), Chifumi Iseki, M.D.1), Yoshimi Takahashi, M.D.1), Manabu Wada, M.D.1), Toru Kawanami, M.D.1), Hidenori Sato, M.D.2) and Mitsuru Emi, M.D.2)
CLINICA NEUROL, 50: 963|965, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Understanding of cerebrospinal fluid hydrodynamics in idiopathic hydrocephalus (A) Visualization of CSF bulk flow with MRI time-spatial labeling pulse method (time-SLIP)
Shinya Yamada, M.D., Ph.D. and Tadateru Goto, M.D.
CLINICA NEUROL, 50: 966|970, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Glycan biomaker in CSF
Yasuhiro Hashimoto, M.D.1), Satoshi Futakawa, M.D.1), Masakazu Miyajima, M.D.2), Shinobu Kitazume, M.D.5), Kiyomitsu Nara, M.D.1), Keiro Shirotani, M.D.1), Atsushi Kuno, M.D.3), Hiromi Ito, M.D.3), Takashi Honda, M.D.4), Katsutoshi Furukawa, M.D.6), Kazuhiro Tasaki, M.D.7), Hiroyuki Arai, M.D.6), Tatsuhiko Yuasa, M.D.8), Masafumi Abe, M.D.7), Hisashi Narimatsu, M.D.3) and Hajime Arai, M.D.2)
CLINICA NEUROL, 50: 971|972, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Diagnostic value of CSF biomarker profile in idiopathic normal pressure hydrocephalus;leucine-rich α-2-glycoprotein is a potential biological marker
Madoka Nakajima, M.D., Hajime Arai, M.D. and Masakazu Miyajima, M.D.
CLINICA NEUROL, 50: 973|976, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Aim
Jun Goto1), Hiroshi Takashima2)
CLINICA NEUROL, 50: 977|977, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Inefficient A-to-I RNA editing and ALS
Shin Kwak, M.D.
CLINICA NEUROL, 50: 978|978, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Implications of microRNA dysfunction in the pathogenesis of ALS
Yukio Kawahara, M.D., Ph.D.
CLINICA NEUROL, 50: 979|981, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Double the Trouble: Bidirectional Expression of the SCA8 CAG/CTG Expansion Mutation-Evidence for RNA and Protein Gain of Function Effects
Laura P.W. Ranum, M.D.1)2)4), Randy S. Daughters, M.D.1)2), Daniel L. Tuttle, M.D.4), Wangcai Gao, M.D.3), Yoshio Ikeda, M.D.1)2), Melinda L. Moseley, M.D.1)2), Tim Ebner, M.D.3) and Maurice S. Swanson, M.D.4)
CLINICA NEUROL, 50: 982|983, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
RNA-mediated Disease Mechanism of Spinocerebellar Ataxia Type 10
Tohru Matsuura, M.D.
CLINICA NEUROL, 50: 984|984, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Spinocerebellar ataxia type 31
Kinya Ishikawa, M.D.1), Nozomu Sato, M.D.1), Yusuke Niimi, M.D.1), Takeshi Amino, M.D.1)2) and Hidehiro Mizusawa, M.D.1)
CLINICA NEUROL, 50: 985|987, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 50: 988|988, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
The origin of pain of migraine
Toshihiko Shimizu, M.D., Ph.D
CLINICA NEUROL, 50: 989|989, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Chronification of migraine headache: clinical feature and mechanism of chronic migraine and medication overuse headache
Takao Takeshima, M.D.
CLINICA NEUROL, 50: 990|993, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
The central nervous system in the pathophysiological mechanism of the migraine
Junichi Hamada, M.D.
CLINICA NEUROL, 50: 994|994, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Molecular genetics of migraine applying DNA microarray-based comprehensive resequencing and high throughput linkage analysis system
Yuji Takahashi, M.D.1), Takahiro Iizuka, M.D.2) and Shoji Tsuji, M.D.1)
CLINICA NEUROL, 50: 995|995, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 50: 996|996, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Pain and itch perception in human limbic system
Ryusuke Kakigi, M.D.
CLINICA NEUROL, 50: 997|999, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Insula and disgust
Atsunobu Suzuki, Ph.D.
CLINICA NEUROL, 50: 1000|1002, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Limbic system and autonomic nervous system
Takashi Ueyama, M.D., Ph.D.1) and Emiko Senba, M.D., Ph.D.2)
CLINICA NEUROL, 50: 1003|1006, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
The role of orbitofrontal cortex in moral judgment
Masaru Mimura, M.D., Ph.D.
CLINICA NEUROL, 50: 1007|1009, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Emotion and Brodmann's areas: special reference on area 12
Mitsuru Kawamura, M.D.
CLINICA NEUROL, 50: 1010|1011, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Aim
Mitsuru Kawamura1), Thomas H. Bak2)
CLINICA NEUROL, 50: 1012|1012, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Learning from History-FTD, ALS and Behaviour
Thomas H. Bak, M.D.
CLINICA NEUROL, 50: 1013|1013, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Language in ALS/FTLD
Hiroo Ichikawa, M.D.
CLINICA NEUROL, 50: 1014|1016, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Acquired Savant syndrome in frontotemporal dementia
Keisuke Takahata, M.D.1) and Masaru Mimura, M.D.2)
CLINICA NEUROL, 50: 1017|1017, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Clinicopathological features of sporadic frontotemporal lobar degeneration with TDP-43-positive inclusions
Osamu Yokota, M.D.
CLINICA NEUROL, 50: 1018|1021, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
FTLD/ALS as TDP-43 proteinopathies
Tomohiko Ishihara, M.D.1)2), Yuko Ariizumi, M.D.1)2), Atsushi Shiga, M.D.2), Akio Yokoseki, M.D.1), Tatsuya Sato, M.D.1), Yasuko Toyoshima, M.D.3), Akiyoshi Kakita, M.D.3), Hitoshi Takahashi, M.D.3), Masatoyo Nishizawa, M.D.1) and Osamu Onodera, M.D.2)
CLINICA NEUROL, 50: 1022|1024, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 50: 1025|1025, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
The survey report about the end-of-life care with ALS patients of the ALS physicians in Japan
Mieko Ogino, M.D., Ph.D., MMA
CLINICA NEUROL, 50: 1026|1028, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Withdrawal of life-support from ALS patients in so called totally locked in state:from the viewpoint of clinical ethics
Tetsuro Shimizu, Ph.D.
CLINICA NEUROL, 50: 1029|1030, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Law, judicial precedent and guideline concerning the end period of nerve intractable disease
Kazuto Inaba, M.D.
CLINICA NEUROL, 50: 1031|1032, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 50: 1033|1033, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
How do we develop ICT-based neurology education
Takahiro Amano, M.D.
CLINICA NEUROL, 50: 1034|1036, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
How can be a favorable and effective instructional design (ID) for the future neurologist?
Manabu Doyu, M.D.
CLINICA NEUROL, 50: 1037|1039, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Teaching material for Neurology in the integrated curriculum-development and sharing
Itaru Toyoshima, M.D.
CLINICA NEUROL, 50: 1040|1040, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Education and training in neurology, update
Nobuo Yanagisawa, M.D.
CLINICA NEUROL, 50: 1041|1043, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 50: 1044|1044, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Establishment of an economic foundation for neurologists in Japan
Tetsuya Takayanagi, M.D., Ph.D.1)2) and Ryuji Tamura, M.D.3)
CLINICA NEUROL, 50: 1045|1048, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Toward establishment of the economical basis for medical care of Neurology in Japan-appropriate assessment of techniques for diagnosis and treatments in Neurology
Norihiro Suzuki, M.D., Ph.D., F.A.C.P.
CLINICA NEUROL, 50: 1049|1051, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Economical basis for neurologic services and the system for health insurance: diagnosis procedure combinations and insurance scores of neurophysiological tests
Yoshiyuki Kuroiwa, M.D.
CLINICA NEUROL, 50: 1052|1054, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Explanation method about health economics value of neurology
Tomoyuki Takura, Ph.D.
CLINICA NEUROL, 50: 1055|1057, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 50: 1058|1058, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Analysis of the shortage of doctors in medical university hospital in central Tokyo and plan for future improvements
Kazumasa Yokoyama, M.D.
CLINICA NEUROL, 50: 1059|1062, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
Regional disparities on medical care for neurological diseases in Aomori prefecture
Masahiko Tomiyama, M.D.
CLINICA NEUROL, 50: 1063|1065, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
The state of neurological medical services in the suburbs of Tokyo: The difference between urban regions and rural districts
Takashi Ohashi, M.D.
CLINICA NEUROL, 50: 1066|1068, 2010
The 51st Annual Meeting of the Japanese Society of Neurology
How do we cure the medical divide between northern Tohoku district and Tokyo?
Hikoaki Fukaura, M.D.
CLINICA NEUROL, 50: 1069|1072, 2010